Procurement of Leukapheresis Products From End Stage Liver Disease (ESLD) Patients for Immunological Studies
NCT02447926
·
clinicaltrials.gov ↗
NA
Phase
TERMINATED
Status
1
Enrollment
OTHER
Sponsor class
Stopped
Successful proof of concept study after 1 subject.
Conditions
End Stage Liver Disease
Interventions
PROCEDURE:
Leukapheresis
Sponsor
Northwestern University